# PRO 140 for Human Immunodeficiency Virus Infection

> **NCT02257788** · PHASE2 · WITHDRAWN · sponsor: **Drexel University**

## Conditions studied

- HIV

## Interventions

- **BIOLOGICAL:** PRO 140

## Key facts

- **NCT ID:** NCT02257788
- **Lead sponsor:** Drexel University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-09
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unlikely to achieve targeted accrual
- **Last updated:** 2017-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02257788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02257788, "PRO 140 for Human Immunodeficiency Virus Infection". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT02257788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*